Literature DB >> 1311211

Etiology of primary liver cancer and the role of steroidal hormones.

D Trichopoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1311211     DOI： 10.1007/bf00051905

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN： 0957-5243            Impact factor:   2.506


× No keyword cloud information.
  19 in total

1.  The hepatitis B virus.

Authors:  B S Blumberg
Journal:  Public Health Rep       Date:  1980 Sep-Oct       Impact factor: 2.792

2.  Oral contraceptives and hepatocellular carcinoma.

Authors:  J Neuberger; D Forman; R Doll; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-24

3.  Contraceptive steroids as a risk factor for hepatocellular carcinoma: a case/control study in South African black women.

Authors:  M C Kew; E Song; A Mohammed; J Hodkinson
Journal:  Hepatology       Date:  1990-02       Impact factor: 17.425

4.  Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States.

Authors:  M C Yu; M J Tong; P Coursaget; R K Ross; S Govindarajan; B E Henderson
Journal:  J Natl Cancer Inst       Date:  1990-06-20       Impact factor: 13.506

5.  Risk factors for hepatocellular carcinoma in Catalonia, Spain.

Authors:  M V Mayans; X Calvet; J Bruix; M Bruguera; J Costa; J Estève; F X Bosch; C Bru; J Rodés
Journal:  Int J Cancer       Date:  1990-09-15       Impact factor: 7.396

6.  Oral contraceptive use and liver cancer.

Authors:  J R Palmer; L Rosenberg; D W Kaufman; M E Warshauer; P Stolley; S Shapiro
Journal:  Am J Epidemiol       Date:  1989-11       Impact factor: 4.897

7.  Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma.

Authors:  E Kaklamani; D Trichopoulos; A Tzonou; X Zavitsanos; Y Koumantaki; A Hatzakis; C C Hsieh; S Hatziyannis
Journal:  JAMA       Date:  1991-04-17       Impact factor: 56.272

8.  Combined oral contraceptives and liver cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.

Authors: 
Journal:  Int J Cancer       Date:  1989-02-15       Impact factor: 7.396

9.  Oral contraceptives and primary liver cancer.

Authors:  C La Vecchia; E Negri; F Parazzini
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

10.  Hepatocellular carcinoma and oral contraceptives.

Authors:  B E Henderson; S Preston-Martin; H A Edmondson; R L Peters; M C Pike
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640
View more
  5 in total

Review 1.  Oral contraceptives and cancer. A review of the evidence.

Authors:  C La Vecchia; A Tavani; S Franceschi; F Parazzini
Journal:  Drug Saf       Date:  1996-04       Impact factor: 5.606

2.  Risk factors for hepatocellular carcinoma among Japanese women.

Authors:  K Tanaka; T Hirohata; K Fukuda; A Shibata; H Tsukuma; T Hiyama
Journal:  Cancer Causes Control       Date:  1995-03       Impact factor: 2.506

3.  Female hormone utilisation and risk of hepatocellular carcinoma.

Authors:  A Tavani; E Negri; F Parazzini; S Franceschi; C La Vecchia
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

4.  Trends in mortality from primary liver cancer in England and Wales 1975-92: influence of oral contraceptives.

Authors:  J W Mant; M P Vessey
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

5.  Cumulative risk of hepatocellular carcinoma in hepatitis C virus carriers: statistical estimations from cross-sectional data.

Authors:  H Tanaka; T Hiyama; H Tsukuma; I Fujimoto; H Yamano; Y Okubo; A Kitada
Journal:  Jpn J Cancer Res       Date:  1994-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.